MIRA Pharmaceuticals, Inc. (MIRA) stock
MIRANasdaqPharmaceutical Preparations
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 12, 2026Score 6/30
$0.59−0.05 (-7.66%)
Close on Nov 18, 2026Market cap $24.84MP/E –Yield –
MIRA Pharmaceuticals EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
No ev/ebitda figures for MIRA Pharmaceuticals
MIRA Pharmaceuticals has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?